Skip to content
Open access

A targeted mutational strategy aiding in generating antisense RNA to knockdown the Ehrlichia chaffeensis P28-outer membrane protein 19 expression

Aug 2026 · Journal of Bacteriology · Vol 208 · 0 citations · 80 references
Medicine

TL;DR

An innovative targeted mutational approach leading to expression of an antisense RNA facilitating the knockdown of p28-Omp19 protein expression from E. chaffeensis to express specific antisense RNA (asRNA) to knockdown protein synthesis from a gene.

Abstract

ABSTRACT Obligate intracellular pathogenic bacteria belonging to the order Rickettsiales include several important emerging pathogens causing major health and economic impact to humans, companion animals, and agricultural animals. Despite some recent progress, the lack of well-established genetic manipulation methods for diverse research applications remains a challenge. We recently reported the establishment of targeted mutagenesis to disrupt genes in Ehrlichia and Anaplasma species. Many essential genes of the obligate pathogens, such as Ehrlichia chaffeensis, are likely refractory to targeted mutagenesis; thus, we developed a novel targeted mutational approach leading to expression of an antisense RNA facilitating the knockdown of p28-Omp19 protein expression from ECH_1143. This gene was selected as its encoded protein is among the highly immunogenic proteins of E. chaffeensis, and our prior efforts to generate a loss-of-function mutation were unsuccessful. This method involved introducing a mutation at a distal genomic location within the E. chaffeensis genome, allowing generating a 209-nucleotide-long antisense RNA that is complementary to ECH_1143 sense mRNA expressed from the same gene promoter, duplicated in the genome during mutagenesis. The mutational strategy was designed to retain the surrounding genomic regions unaltered. The antisense knockdown mutation resulted in a reduction of p28-Omp19 expression relative to wild-type E. chaffeensis during its replication in a macrophage cell line, where the gene expression is known to occur, and the mutation caused a fitness defect. We anticipate that this novel mutational strategy will be broadly applicable to facilitate investigating essential genes of obligate intracellular bacterial pathogens. IMPORTANCE We developed an innovative targeted mutagenesis approach in the obligate intracellular bacterium Ehrlichia chaffeensis to express specific antisense RNA (asRNA) to knockdown protein synthesis from a gene. The mutational strategy was carefully designed to retain the genomic sequences surrounding the mutational site unaltered. Our data demonstrate that this asRNA system effectively reduces protein synthesis by the unique mutational strategy and is ideal for investigating genes critical for the bacterial replication in vitro. This innovative molecular tool facilitates research in investigating essential gene research in E. chaffeensis and holds strong potential to extend similar research on other bacterial pathogens having reduced genomes. We developed an innovative targeted mutagenesis approach in the obligate intracellular bacterium Ehrlichia chaffeensis to express specific antisense RNA (asRNA) to knockdown protein synthesis from a gene. The mutational strategy was carefully designed to retain the genomic sequences surrounding the mutational site unaltered. Our data demonstrate that this asRNA system effectively reduces protein synthesis by the unique mutational strategy and is ideal for investigating genes critical for the bacterial replication in vitro. This innovative molecular tool facilitates research in investigating essential gene research in E. chaffeensis and holds strong potential to extend similar research on other bacterial pathogens having reduced genomes.

Read PDF

Similar papers

Open access Jul 2026

Harnessing endogenous CRISPR-Cas9 for inducible genetic engineering of Apilactobacillus kunkeei

An inducible genome-editing framework exploiting the endogenous Cas9 system of Apilactobacillus kunkeei, a key member of the honeybee microbiota, is established and the toolkit available for harnessing endogenous CRISPR-Cas systems in genetically recalcitrant, non-model gram-positive bacteria is expanded.

Mahesh S. Iyer, Erik Hagström, Kristina Näslund et al. · 0 citations
Open access Aug 2026

Repeated mutation of a GT92 glycosyltransferase gene confers antiviral resistance in two Caenorhabditis species

Abstract Host–pathogen interactions evolve rapidly within species, providing natural genetic resources for the identification of specific ecological interaction factors. We previously identified RNA viruses that infect the nematodes Caenorhabditis elegans and Caenorhabditis briggsae in a species-specific manner. Wild s...

Aurélien Richaud, Gaotian Zhang, Cigdem Alkan et al. · 0 citations
2026

A Conditional Plasmid System for Markerless Gene Deletion in Genetically Recalcitrant Fusobacterium nucleatum subsp. animalis.

This chapter provides a detailed, step-by-step protocol for implementing a conditional plasmid system that enables efficient, markerless gene deletion in FNA strains and provides a powerful and adaptable tool for advancing genetic studies in this genetically recalcitrant subspecies.

B. C., Chenggang Wu · 0 citations
Open access Jul 2026

RNAi-based therapeutics targeting the F gene in human metapneumovirus: An in-silico approach

This study identified F11 as the most promising siRNA candidate targeting the highly conserved HMPV fusion (F) gene, demonstrating strong potential as an RNAi-based therapeutic agent according to computational analyses.

Proshanto Ghosh, Md. Nur Islam, Shahriar Hossain et al. · 0 citations
Open access Jul 2026

Plasmid-driven evolution of a multi-drug resistant ETEC/ExPEC hybrid E. coli associated with neonatal septicemia in lambs, a challenge for veterinary diagnostics.

This case highlights how horizontal gene transfer promotes the development of hybrid pathotype and facilitates resistance genes acquisition, compromising traditional diagnostic approaches and treatment of atypical E. coli strains such as those with hybrid pathotypes.

M. de Lagarde, G. Vanier, J. Fairbrother et al. · 1 citation
Open access Aug 2026

Minimal organism JCVI-syn3.0, an engineered derivative of Mycoplasma mycoides, encodes an assortment of unrecognized membrane transporters and immunity factors

The intrinsic sequence characteristics, evolutionary conservation, and three-dimensional AlphaFold models of this least understood subset of the JCVI-Syn3.0 genes, a derivative of Mycoplasma mycoides subsp.

A. Mushegian, Phillip K. Yamamoto, Naoki Torikai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.